JARDIANCE (EMPAGLIFLOZIN) Patient Assistance Program

Don’t let the cost of your diabetes, heart failure, or kidney disease medication put your health at risk. We help eligible patients access brand-name Jardiance for $69.95 per month through the manufacturer’s Patient Assistance Program.

HIPAA Compliant

BBB Accredited

Secure Website

Key ​Takeaways:

What Is Jardiance Prescription Assistance Program?

The Jardiance Prescription Assistance Program is a manufacturer-sponsored initiative run by the manufacturer’s Patient Assistance Program that provides brand-name Jardiance at no medication cost to qualifying patients based on income and insurance status. The program is designed for uninsured and
underinsured individuals, and it may also accept Medicare patients in certain circumstances. If approved, you can receive your medication free of charge, typically shipped directly to you or your doctor’s office, and the program can be renewed as needed.

The application process involves eligibility verification, prescriber coordination, income documentation, and periodic re-enrollment — and the requirements can change without notice. AffordMyPrescriptions removes that complexity entirely. For a flat $69.95 per month, our Patient Advocates manage every step of your enrollment, from initial application through ongoing refills and annual re-enrollment.

Pharmacy Price Comparison

Pharmacy(With Coupon) PrIce (30-Day)* You Save W/ Us
Walgreens

~$367.76

Save ~$298/mo

CVS Pharmacy

~$378.09

Save ~$308/mo

Walmart

~$369.31

Save ~$299/mo

*Just a heads-up — retail prices are estimates based on public data and vary by pharmacy. AffordMyPrescriptions Advocacy Service bypasses this by using drug manufacturer programs to secure your medication directly at no cost or retail price.

Our Pricing:

$69.95 Per month

1 Medications

$79.95 Per Month

2 Medications

$89.95 Per Month

3 Medications

$99.95 Per Month

4+ Medications

Why choose us For Your Jardiance Prescription Program?

When you’re managing diabetes, heart failure, or kidney disease, the last thing you should worry about is whether you can afford the medication keeping you healthy. Yet navigating pharmaceutical assistance programs is complex and time-consuming — each has its own eligibility rules, forms, timelines, and renewal deadlines, and they can change without notice. At AffordMyPrescriptions, trained, experienced Patient
Advocates manage the entire process on your behalf. Your cost is $69.95 per month — every month, no exceptions. No hidden fees, no savings caps, no prices that change. If we’re unable to secure access to your medication, you won’t be charged.

Enroll

Complete a simple eligibility form so our team can determine if you may qualify for medication assistance programs.

We Advocate

Our specialists help gather documentation, complete applications, and coordinate with program providers.

Receive Medication

Once approved, you may receive your medication through the assistance program while we help manage ongoing paperwork and renewals.

Discount Coupons vs. Patient Assistance Programs

Discount coupons from GoodRx and SingleCare can reduce the cost of Trulicity, and the manufacturer’s savings card offers eligible commercially insured patients costs as low as $25 per fill. These programs provide real help — but they have significant limitations for long-term diabetes treatment. Here’s why the PAP through AffordMyPrescriptions is the better solution for patients who qualify:

Limitations of Coupons

  • Prices fluctuate — savings aren’t guaranteed month-to-month
  • Copay accumulators may prevent savings from counting toward deductible
  • Cards expire and require constant renewal
  • Subject to strict monthly or annual maximum savings caps
  • Can’t be used with Medicare, Medicaid, or government insurance

Advantages of PAP Through Us

  • Fixed $69.95/month — never changes regardless of retail price
  • No expiration — continuous access as long as you qualify
  • Medication supplied directly from the manufacturer
  • We manage all paperwork, refills, and renewals
  • If denied, we explore alternative savings on your behalf

DO YOU QUALIFY?

Eligibility is generally determined by annual household income levels. Most programs follow guidelines that include a limit of up to $40,000 for individuals, $60,000 for couples, and $100,000 for larger families. Because these requirements can vary, we encourage you to contact Afford My Prescriptions directly so we can review your specific situation and determine if you qualify for assistance.

Understanding Jardiance:

Jardiance (empagliflozin) has become one of the most important medications in modern chronic disease management. Originally approved to help lower blood sugar in adults with type 2 diabetes, its indications expanded as clinical trials revealed powerful cardiovascular and renal benefits. Jardiance was the first diabetes medication to demonstrate a significant reduction in the risk of cardiovascular death in a landmark clinical trial. It is now prescribed to reduce hospitalizations for heart failure and to slow the progression of chronic kidney disease — even in patients who do not have diabetes. It was also selected as one of the first 10 drugs for Medicare price negotiation under the IRA, with a reduced negotiated price in effect as of January 2026.


How Jardiance Works:

Your kidneys normally filter sugar (glucose) out of your blood and then reabsorb most of it back into your bloodstream through a protein called SGLT2. Jardiance works by blocking the SGLT2 protein, preventing your kidneys from reabsorbing glucose — instead, the excess sugar is passed out of your body through urine. By also causing your body to excrete sodium, Jardiance reduces blood volume and blood pressure, taking strain
off your heart. You take one tablet once daily, in the morning, with or without food.

Generic Availability:

As of April 2026, no generic version of Jardiance (empagliflozin) is available at U.S. pharmacies. Although the FDA has granted tentative approval to generic empagliflozin applications, these products cannot be marketed until relevant patent protections expire. The primary patents have expiration dates in the 2026–2027 range, but additional formulation and method-of-use patents extend protection further. Some analysts now expect generic empagliflozin could launch in late 2026 or early 2027 based on ongoing patent litigation, though other analyses suggest generic entry could be delayed until 2029 or beyond. Until generic empagliflozin becomes commercially available, Jardiance will remain a brand-only product, making the the manufacturer’s PAP PAP the most affordable access pathway for qualifying patients.

How Trulicity Works:

The Once-Weekly GLP-1 That Mimics Your Body’s Natural Hormone for Powerful Blood Sugar Control, Appetite Support & Heart Protection

Description (ready to use on your website content page):

 

When you eat, your body naturally produces a hormone called GLP-1 (glucagon-like peptide-1) in your intestines. This hormone signals your pancreas to release insulin, tells your liver to produce less glucose, and slows the movement of food through your stomach — helping prevent blood sugar spikes after meals and helping you feel full longer.

In people with type 2 diabetes, this natural GLP-1 system doesn’t work as effectively as it should. Trulicity (dulaglutide) is a synthetic GLP-1 receptor agonist that perfectly mimics the actions of your body’s own hormone — but it’s engineered to last dramatically longer. While natural GLP-1 is broken down within minutes, Trulicity stays active in your system for a full week. That’s why you only need one simple injection per week.

Trulicity works in multiple ways to help manage type 2 diabetes:

  • It stimulates insulin release when blood sugar is elevated
  • It suppresses glucagon (the hormone that raises blood sugar)
  • It slows gastric emptying so food leaves your stomach more gradually
  • It reduces appetite, supporting modest weight loss

These combined actions not only improve blood sugar control but also deliver proven cardiovascular benefits — making Trulicity a powerful, once-weekly treatment option for many patients.

Biosimilar Availability

As of April 2026, there is no generic or biosimilar version of Trulicity (dulaglutide) available in the United States or anywhere in the world. Because Trulicity is a biologic medication made from living organisms (not a simple chemical compound), it cannot have a traditional generic. Any lower-cost alternative must be an approved biosimilar that undergoes its own extensive clinical testing to prove it is highly similar to the original.

The primary compound patent for Trulicity remains protected until 2027. Even after patent expiry, the development and FDA approval process for a biosimilar typically takes several years. As a result, a biosimilar version of Trulicity is not expected to reach U.S. pharmacies until 2028 at the earliest.

Until then, Trulicity remains available only as a premium brand-name product. This makes the Lilly Cares Patient Assistance Program (accessed through AffordMyPrescriptions for just $50 per month) the most effective and reliable way for eligible patients to access their prescribed Trulicity at no medication cost — especially when out-of-pocket coupon prices can still reach $825–$1,116+ per month.

 

 

FAQ (Frequently Asked Questions)

How much does Jardiance cost without insurance?

The average retail price is approximately $600–$831 per month for 30 tablets. With GoodRx coupons, you may pay $355–$378/month at most pharmacies. SingleCare offers prices as low as ~$255/month. Through AffordMyPrescriptions, qualifying patients receive Jardiance at no medication cost — our $69.95 monthly fee covers advocacy and program management.

Yes. The Jardiance supplied through the assistance program is the exact same brand-name, FDA-approved empagliflozin tablet. It is identical to what any retail pharmacy would dispense.

The manufacturer’s assistance program does evaluate Medicare patients on a case-by-case basis. Additionally, Jardiance was one of the first 10 drugs selected for Medicare price negotiation under the Inflation Reduction Act, with a reduced negotiated price in effect as of January 2026. Medicare Part D beneficiaries also benefit from the $2,100 annual out-of-pocket cap. Contact AffordMyPrescriptions and we’ll help you determine the most affordable option for your situation.

Our Patient Advocates will immediately explore every alternative — including the Jardiance Savings Card ($10/month for commercially insured patients), GoodRx and SingleCare coupons ($255–$378/month), independent co-pay assistance foundations, and alternative SGLT2 inhibitors (such as Farxiga, which currently has a manufacturer-backed GoodRx discount of ~$288/month) that may have better coverage on
your plan. We don’t stop until we find a solution.

Our Patient Advocates will immediately explore every alternative — including the Trulicity Savings Card (as low as $25/fill for commercially insured patients, with $150/month max savings and $1,800 annual cap), GoodRx and SingleCare coupons (~$825–$1,116/month), independent co-pay assistance foundations, and alternative GLP-1 or diabetes medications that may have better coverage on your insurance plan. We don’t stop until we find a solution.

Take Control of Your Medication Costs

If you’re struggling with the high cost of Jardiance, our team can help you access assistance programs
designed to make your diabetes, heart, or kidney treatment more affordable.

Submit Enrollment Form

Start free by filling out a simple online form.

Receive Welcome Call

Our specialist will contact you for a quick welcome call.

We Manage The Process

Our team handles everything, so you can focus on your health.

Receive Welcome Call

We Manage The Process